Skip to main content
  • What's Left on the Horizon From First-Gen Absorb BVS? The device went bust, but there's still data coming

    When Abbott decided pull the first-generation Absorb bioresorbable vascular scaffold (BVS) from the market in September, investigators had to stop recruiting patients for ongoing studies.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details